HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 22, No 06, June 2018 – Cancer - Therapies and strategies for better patient outcomes       » Gardasil 9 supply running short in Hong Kong       » China helps Tajikistan tackle grassland degradation       » Immuno-oncology trials in China surge more than 50 per cent       » Yeast for industrial biotechnology       » Uncontrolled hypertension in rural communities      
BIOBOARD - SINGAPORE
Clearbridge BioMedics makes a big impact at the 2012 Asian Innovation Awards
Clearbridge BioMedics has won the top three awards at the Asian Innovation Awards 2012. It took the grand prize which recognizes innovations that break conventional processes to improve quality of life or productivity. It also received the Credit Suisse Technopreneur of the Year Award, which honors the entry that best applies technology with the greatest potential for commercial success. The Company proved to be well-liked amongst the guests at the event, and also claimed the Audience Choice Award. Clearbridge BioMedics beat 11 other finalists who were vying for these awards and who had been short-listed from more than 240 applications. The Asian Innovation Awards 2012 were presented by The Wall Street Journal in partnership with Credit Suisse.

“Innovation and entrepreneurship play essential roles in driving economic growth across the Asia-Pacific region,” said Dan Molloy, global executive director for multimedia sales, Asia, for The Wall Street Journal. “The Wall Street Journal is pleased to continue to recognize some of Asia's most creative business ideas and to celebrate the region's newest technological advances and innovations. My congratulations to Clearbridge BioMedics on their ingenuity and success in this year's Asian Innovation Awards.”

Johnson Chen, Founder of Clearbridge BioMedics, said: “Clearbridge BioMedics is absolutely delighted and honored to win, not one but three awards, at the Asian Innovation Awards. This fantastic win is a nice validation of our work, and for the need to find better ways to diagnose, treat and conduct research on cancer. We aim to further develop our ClearCell™ System into a health-care solution that will empower cancer clinicians and researchers to manage cancer in a more effective manner,”

Clearbridge BioMedics is a spin-off company from the Faculty of Engineering, National University of Singapore. Its proprietary ClearCell™ System is able to effectively detect, isolate and retrieve wholly-intact circulating tumour cells from patients’ blood samples. This has numerous applications in the areas of cancer screening, diagnosis and treatment monitoring. The ClearCell™ System has achieved ISO13485 certification, and is available for the cancer research market.

Click here for the complete issue.

NEWS CRUNCH  
news Shire, Microsoft and EURORDIS form Global Commission to accelerate time to diagnosis for children with rare diseases
news EmTech Asia explores future of life, humanity and economy
news Biology of Ageing II - Impactful Interventions
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  
COLUMNS  
Click here to receive APBN e-newsletters once a month!

APBN Editorial Calendar 2018
January:
Obesity / Outlook for 2018
February:
Searching for the fountain of youth
March:
Women in Science - Making a difference
April:
Digestive health in the 21st century - Trust your guts
May:
Dental health - The root to good health
June:
Cancer - Therapies and strategies for better patient outcomes
July:
Water management / Vaccination
August:
Regenerative medicine / Biotech start ups
September:
Digital healthcare / 3D printing
October:
Bones / Breast cancer
November:
Liver health / Top science research nations & institutions
December:
AIDS / Breakthrough of the year/Emerging trends
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2018 World Scientific Publishing Co Pte Ltd  •  Privacy Policy